日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System

新的经验证的轻链(AL)淀粉样变性分期系统,其中IIIC期定义了超高危:AL国际分期系统

Khwaja, Jahanzaib; Kirkwood, Amy A; Milani, Paolo; Yohannan, Binoy; Theodorakakou, Foteini; Weverling, Flores; Di Simone, Valeria; Ravichandran, Sriram; Kumar, Shaji; Petropoulos, Ioannis; Mussinelli, Roberta; Cohen, Oliver; Oerlemans, Marish I F J; Muchtar, Eli; Stamatelopoulos, Kimon; Lachmann, Helen J; Gillmore, Julian D; Briasoulis, Alexandros; Gertz, Morie; Whelan, Carol; Venneri, Lucia; Fontana, Marianna; Mahmood, Shameem; Schwotzer, Rahel; Minnema, Monique C; Dispenzieri, Angela; Palladini, Giovanni; Kastritis, Efstathios; Wechalekar, Ashutosh

Belantamab mafodotin, lenalidomide, and dexamethasone for intermediate-fit and frail patients with newly diagnosed myeloma

贝兰他单抗、来那度胺和地塞米松用于治疗中等体能和体弱的新诊断多发性骨髓瘤患者

Terpos, Evangelos; Gavriatopoulou, Maria; Ntanasis-Stathopoulos, Ioannis; Malandrakis, Panagiotis; Fotiou, Despina; Kanellias, Nikolaos; Migkou, Magdalini; Theodorakakou, Foteini; Spiliopoulou, Vasiliki; Solia, Eirini; Eleutherakis-Papaiakovou, Evangelos; Psarros, Giorgos; Kastritis, Efstathios; Dimopoulos, Meletios A

Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy

多发性骨髓瘤合并急性肾衰竭至管型肾病患者的肾功能恢复和生存相关参数

Ludwig, Heinz; Dimopoulos, Meletios Athanasios; Terpos, Evangelos; Bernhard, Sarah; Theodorakakou, Foteini; Beksac, Meral; Cengiz-Seval, Guldane; Leung, Nelson; Arcaini, Luca; Mangiacavalli, Silvia; Bridoux, Frank; Agis, Hermine; Chaidos, Aristeidis; Gay, Francesca; Roccatello, Dario; Hilbe, Wolfgang; Havasi, Andrea; Derudas, Daniele; Klomjit, Nattawat; Jhaveri, Kenar D; De La Rubia Comos, Javier; Kastritis, Efstathios

Circulating tumor cells by Next Generation Flow Cytometry as a new prognostic biomarker for patients with asymptomatic monoclonal gammopathies

利用新一代流式细胞术检测循环肿瘤细胞作为无症状单克隆丙种球蛋白病患者的新型预后生物标志物

Kastritis, Efstathios; Malandrakis, Panagiotis; Kostopoulos, Ioannis V; Ntanasis-Stathopoulos, Ioannis; Solia, Irene; Theodorakakou, Foteini; Spiliopoulou, Vasiliki; Fotiou, Despina; Migkou, Magdalini; Kanellias, Nikolaos; Eleutherakis-Papaiakovou, Evangelos; Taouxi, Konstantina; Papadimou, Alexandra; Liacos, Christine-Ivy; Gavriatopoulou, Maria; Tsitsilonis, Ourania; Terpos, Evangelos; Dimopoulos, Meletios-Athanasios

Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy

对接受初始抗克隆治疗前需透析的系统性免疫球蛋白轻链淀粉样变性患者进行特征分析、结局评估及预后因素识别。

Sester, Lilli S; Milani, Paolo; Theodorakakou, Fenia; Dittrich, Tobias; Beimler, Jörg; Aus dem Siepen, Fabian; Zeier, Martin; Raab, Marc-Steffen; Müller-Tidow, Carsten; Kastritis, Efstathios; Palladini, Giovanni; Hegenbart, Ute; Schönland, Stefan O

Bone disease burden does not impact overall survival in newly diagnosed patients with multiple myeloma - a single center, retrospective imaging analysis on 119 patients

骨骼疾病负担不影响新诊断多发性骨髓瘤患者的总生存期——一项纳入119例患者的单中心回顾性影像学分析

Terpos, Evangelos; Koutoulidis, Vassilis; Ntanasis-Stathopoulos, Ioannis; Mavropoulos-Papoudas, Stylianos; Douka, Maria; Gavriatopoulou, Maria; Malandrakis, Panagiotis; Spiliopoulou, Vasiliki; Theodorakakou, Foteini; Fotiou, Despina; Migkou, Magdalini; Kanellias, Nikolaos; Eleutherakis-Papaiakovou, Evangelos; Kastritis, Efstathios; Moulopoulos, Lia-Angela; Dimopoulos, Meletios A

Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma

采用基于Elecsys的血清B细胞成熟抗原检测方法评估的血清B细胞成熟抗原水平升高,对新诊断的多发性骨髓瘤患者具有不良预后价值。

Terpos, Evangelos; Ntanasis-Stathopoulos, Ioannis; Malandrakis, Panagiotis; Fotiou, Despina; Migkou, Magdalini; Eleutherakis-Papaiakovou, Evangelos; Theodorakakou, Foteini; Roussou, Maria; Gavriatopoulou, Maria; Dimopoulos, Meletios A; Kastritis, Efstathios

Single-cell analysis of MYD88(L265P) and MYD88(WT) Waldenström macroglobulinemia patients

对 MYD88(L265P) 和 MYD88(WT) 华氏巨球蛋白血症患者进行单细胞分析

Bagratuni, Tina; Aktypi, Foteini; Theologi, Ourania; Sakkou, Maria; Verrou, Kleio Maria; Mavrianou-Koutsoukou, Nefeli; Patseas, Dimitrios; Liacos, Christine; Skourti, Stamatia; Papadimou, Alexandra; Taouxi, Kostantina; Theodorakakou, Foteini; Kollias, Georgios; Sfikakis, Petros; Terpos, Evangelos; Dimopoulos, Meletios A; Kastritis, Efstathios

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity

在对达雷妥尤单抗和免疫调节剂均耐药的多发性骨髓瘤患者中,联合使用免疫调节剂(IMiDs)可增强疗效并改善免疫调节:重置协同活性

Kostopoulos, Ioannis V; Fotiou, Despina; Gavriatopoulou, Maria; Rousakis, Pantelis; Ntanasis-Stathopoulos, Ioannis; Panteli, Chrysanthi; Malandrakis, Panagiotis; Migkou, Magdalini; Angelis, Nikolaos; Kanellias, Nikolaos; Eleutherakis-Papaiakovou, Evangelos; Theodorakakou, Foteini; Krevvata, Maria; Terpos, Evangelos; Dimopoulos, Meletios-Athanasios; Tsitsilonis, Ourania; Kastritis, Efstathios

Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II study

Belantamab mafodotin、来那度胺和地塞米松治疗不适合移植的新诊断多发性骨髓瘤患者:一项 I/II 期研究的第一部分结果

Terpos, Evangelos; Gavriatopoulou, Maria; Ntanasis-Stathopoulos, Ioannis; Malandrakis, Panagiotis; Fotiou, Despina; Migkou, Magdalini; Theodorakakou, Foteini; Spiliopoulou, Vasiliki; Kostopoulos, Ioannis V; Syrigou, Rodanthi-Eleni; Eleutherakis-Papaiakovou, Evangelos; Gkolfinopoulos, Stavros; Tsitsilonis, Ourania E; Kastritis, Efstathios; Dimopoulos, Meletios A